Dihydrostreptomycin is an aminoglycoside antibiotic obtained through the catalytic hydrogenation of streptomycin, historically utilized to treat bacterial infections but now largely reserved for veterinary… Read more
Dihydrostreptomycin is an aminoglycoside antibiotic obtained through the catalytic hydrogenation of streptomycin, historically utilized to treat bacterial infections but now largely reserved for veterinary medicine due to toxicity concerns in humans. This category provides access to high-quality Dihydrostreptomycin reference standards, which are critical for laboratories conducting impurity profiling, method validation, and rigorous quality control. The collection includes pharmacopeial and non-pharmacopeial impurities, as well as relevant metabolites and stable isotope-labelled compounds, which serve as essential tools for accurate identification and quantification. These analytical standards enable researchers and regulatory professionals to ensure precision during pharmaceutical analysis, support stability testing, and maintain compliance with established standards in both human and veterinary drug development workflows.